Sensyne Health PLC develops clinically validated software applications powered by artificial intelligence including prescribed digital therapeutics and hospital systems for clinical care. Its products connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research and improving patient outcomes. The company's segments include Healthcare and Life Sciences. It generates maximum revenue from the Healthcare segment. Geographically, it derives a majority of revenue from the United Kingdom.
